Apple News+
Apple News+[edit | edit source]
Apple News+ is a subscription-based service offered by Apple Inc. that provides access to a wide range of digital magazines and newspapers. Launched on March 25, 2019, Apple News+ is an extension of the existing Apple News app, which aggregates news stories from various publishers.
History[edit | edit source]
Apple News+ was announced during an Apple Special Event held at the Steve Jobs Theater in Cupertino, California. The service was introduced as part of Apple's strategy to expand its services division, alongside other offerings such as Apple TV+, Apple Arcade, and Apple Card.
The service was initially launched in the United States and Canada, with plans to expand to other countries. Apple News+ was built upon the acquisition of Texture, a digital magazine subscription service, which Apple acquired in 2018.
Features[edit | edit source]
Apple News+ offers subscribers access to over 300 magazines, leading newspapers, and digital publishers. Some of the notable publications available include The Wall Street Journal, Los Angeles Times, National Geographic, and Vogue.
User Interface[edit | edit source]
The service is integrated into the Apple News app, which is available on iOS, iPadOS, and macOS devices. The interface is designed to be user-friendly, with curated content and personalized recommendations based on the user's interests.
Offline Reading[edit | edit source]
Subscribers can download articles for offline reading, allowing them to access content without an internet connection. This feature is particularly useful for users who travel frequently or have limited internet access.
Family Sharing[edit | edit source]
Apple News+ supports Family Sharing, allowing up to six family members to share a single subscription at no additional cost. This feature makes it a cost-effective option for families who consume a lot of digital content.
Pricing[edit | edit source]
As of its launch, Apple News+ is priced at $9.99 per month in the United States and $12.99 per month in Canada. Apple offers a one-month free trial for new subscribers, allowing them to explore the service before committing to a subscription.
Criticism and Challenges[edit | edit source]
While Apple News+ has been praised for its extensive content library and seamless integration with Apple devices, it has faced criticism regarding revenue sharing with publishers. Some publishers have expressed concerns about the financial viability of the service, as Apple takes a 50% cut of the subscription revenue, with the remaining 50% distributed among publishers based on user engagement.
Additionally, the service has been criticized for its limited availability outside of North America and for not including certain major publications, which could affect its appeal to potential subscribers.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
